PharmaCielo Commends Canadian Government for Leadership at United Nations General Assembly Special Session on the World Drug Problem

TORONTO, April 20, 2016 /CNW/ - Jon Ruiz, President and CEO of PharmaCielo Ltd., a global company privately held and headquartered in Canada, with a focus on processing and supplying all natural, medicinal-grade cannabis oil throughout the world, made the following statement today:

"On behalf of PharmaCielo Ltd. I commend Canada's Minister of Health, the Hon. Jane Philpott for representing the Government of Canada at the United Nations General Assembly Special Session on the World Drug Problem (UNGASS 2016) and for taking a prominent leadership role in the global effort to eradicate the cannabis black market. 

The Minister of Health's commitment to keep the profits from the cannabis market out of the hands of criminals and ending the black market in Canada, has put the country at the forefront of this important international policy discussion.

This legalization of cannabis is a complex endeavor and Canada's Prime Minister should be commended for demonstrating leadership on the eradication of the black market and working towards implementing a responsible plan to move forward.  

With countries around the world being ravaged by the drug war, it is time for leaders to take the necessary steps to end the prohibition of cannabis and open the door to examine the best practices to supply consumers with the safest, highest quality product at an accessible cost to the public.

PharmaCielo Ltd. is committed to offering high-quality, medicinal-grade cannabis oil extracts and we look forward to working with the Government of Canada during the ongoing consultation process."

About PharmaCielo:

PharmaCielo Ltd., is a global company privately held and headquartered in Canada.  Wholly owned subsidiary PharmaCielo Colombia Holdings S.A.S maintains operations in Rionegro, Colombia and has applied for licenses from the Colombian government with a focus on processing and supplying all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors of standardized medical cannabis products, finished goods producers, research organizations and pharmaceutical companies.

The board of directors and executive team of PharmaCielo Ltd. are comprised of a diversely talented group of international business executives and specialists with expertise in security, quality and plant growth to ensure long-term success.  The team recognized the significant role Colombia's ideal location would play in building a sustainable business in the medical cannabis industry and has built a strong business plan focused on supplying the international medical marketplace.

For further information:
www.pharmacielo.com

SOURCE PharmaCielo

Media Relations: David Gordon, Tel: [phone], [email protected]; Investor Inquiries: [email protected]